Epithalon

Description

Epithalon (also written Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) associated with the St. Petersburg Institute of Bioregulation and Gerontology and the work of Professor Vladimir Khavinson. It has been studied for effects on aging-related biomarkers, including telomerase activity and telomere dynamics, largely in cell and animal research and select human studies reported by the originating research groups.

Key claim in the literature: Epithalon has been reported to stimulate telomerase activity in certain cell types under experimental conditions.

Dosing Protocols

Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
Typical daily dose: 5,000 mcg (5 mg) once daily for 20 consecutive days.
Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C; reconstituted: refrigerate at 2–8 °C, avoid freeze-thaw cycles.

Schedule: Daily subcutaneous injections for 20 consecutive days, followed by 4–6 months off-cycle.
Cycle: 20 consecutive days on, then 4–6 months off. Typically 2 cycles per year.
Goal: Support telomere maintenance, melatonin regulation, and geroprotective effects over time.

Frequency: Inject once daily subcutaneously, preferably in the evening or at bedtime to synergize with natural melatonin rhythms. Complete 20 consecutive days, then observe a 4–6 month off-cycle before repeating (typically 2 cycles per year).

Phase Dose Syringe (U-100)
Days 1–20 (Cycle On) 5,000 mcg (5 mg) 100 units (1.00 mL)
Weeks 4–26 (Cycle Off) 0 mcg
Potential Benefits (as studied)
  • Telomerase activation and telomere maintenance signals in cell studies (experimental).
  • Potential modulation of circadian/sleep-related parameters in aging research contexts.
  • Possible immune function changes in aging models.
  • General “geroprotective” signaling effects reported by the originating research groups.
Side Effects
  • Human safety data is limited and heterogeneous.
  • Injection site irritation (if injected).
  • Headache or transient fatigue (anecdotal reports).
  • Allergic reactions are possible with any peptide.
Contraindications / Who Should Avoid
  • Pregnancy/breastfeeding (avoid).
  • Active malignancy or high cancer risk: avoid unless under specialist oversight (telomerase-related concerns).
  • Immunosuppressive therapy or autoimmune conditions: clinician review recommended.
  • Known hypersensitivity.
Stacking Suggestions (Research Context)
  • Often discussed alongside lifestyle anti-aging pillars (sleep, resistance training, metabolic health).
  • If stacking with other “longevity peptides” (e.g., thymic peptides), introduce one variable at a time.
Research Sources (PubMed)
  1. Khavinson VKh et al. Biochemistry (Mosc). 2003. PMID: 12680148
  2. Anisimov VN et al. Mech Ageing Dev. 2001. PMID: 11596260
  3. Khavinson VKh et al. Ontogenez. 2006. PMID: 16913672
  4. Khavinson VKh, et al. Bull Exp Biol Med. 2009. PMID: 20126032
  5. Korkushko OV et al. Adv Gerontol. 2004. PMID: 15632831
  6. Druzhynina NA et al. Bull Exp Biol Med. 2011. PMID: 21436639
Research use only. Epithalon (Epitalon) is not FDA-approved. This is educational content, not medical advice.

Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).

Scroll to Top